TIDMAGL
RNS Number : 0798D
Angle PLC
25 June 2021
THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION
CONTAINED HEREIN (TOGETHER, THIS "ANNOUNCEMENT") IS RESTRICTED AND
IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES,
AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE
REPUBLIC OF IRELAND OR ANY OTHER JURISDICTION IN WHICH SUCH
RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL ("RESTRICTED
JURISDICTION"). THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR
SALE IN THE UNITED STATES. THE SECURITIES DISCUSSED HEREIN HAVE NOT
BEEN AND WILL NOT BE REGISTERED UNDER THE US SECURITIES ACT OF
1933, AS AMENDED (THE "US SECURITIES ACT") AND MAY NOT BE OFFERED
OR SOLD IN THE UNITED STATES ABSENT REGISTRATION OR AN EXEMPTION
FROM REGISTRATION UNDER THE US SECURITIES ACT. NO PUBLIC OFFERING
OF THE SECURITIES DISCUSSED HEREIN IS BEING MADE IN THE UNITED
STATES AND THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN
OFFERING OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA,
CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR THE REPUBLIC OF
IRELAND.
FURTHER, THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY
AND DOES NOT CONSTITUTE AN OFFER TO SELL OR ISSUE OR SOLICITATION
TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE SHARES IN ANGLE PLC IN
ANY JURISDICTION IN WHICH ANY SUCH, OFFER OR SOLICITATION WOULD BE
UNLAWFUL.
25 June 2021
ANGLE plc
("ANGLE" or the "Company")
Result of Accelerated Bookbuild
Funds will allow the Company to pursue major prostate
opportunity
ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy
company, is pleased to announce that, further to the announcement
made yesterday, the Company has successfully raised gross proceeds
of GBP20.0 million by conditionally placing 17,241,380 Placing
Shares at a price of 116 pence per New Ordinary Share with new and
existing investors.
The Issue Price represents a discount of approximately 6.83 per
cent. to the closing mid-market price of an Ordinary Share of
124.50 pence on 23 June 2021. The Placing Shares represent
approximately 7.40 per cent. of the Company's Enlarged Issued Share
Capital.
ANGLE Founder and Chief Executive, Andrew Newland,
commented:
"We would like to thank our shareholders for their continued
strong support and welcome new shareholders to the ANGLE register.
The proceeds from this Placing will enable ANGLE to add to the
current momentum in the commercialisation process of our Parsortix
system and open up new market opportunities in Prostate Cancer
diagnosis, an area of significant medical need. ANGLE looks forward
to announcing further progress on multiple fronts in H2 CY21,
including the prospect of FDA clearance for the Parsortix
platform."
Use of Proceeds:
Prostate cancer opportunity GBP7m
Building senior management team in the United States GBP3m
-------
Assay development capability GBP2m
-------
Ongoing operations for breast and ovarian cancers and strengthen balance sheet for pharma GBP8m
services
-------
Total GBP20m
-------
Admission
The Placing is conditional, inter alia, upon the Admission
becoming effective. Application has been made to the London Stock
Exchange for the 17,241,380 New Ordinary Shares to be admitted to
trading on AIM ("Admission") and, subject to the Placing Agreement
not having been terminated in accordance with its terms, it is
expected that Admission will become effective and trading will
commence at 8.00 a.m. on 1 July 2021.
On Admission, the total number of Ordinary Shares in issue will
be 233,109,225 and the total number of voting rights will therefore
be 233,109,225. This figure may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the share capital of the Company under the FCA's
Disclosure Guidance and Transparency Rules.
Capitalised terms not otherwise defined in this announcement
shall have the same meaning ascribed to such terms in the
announcement released yesterday under RNS number 0748D unless the
context requires otherwise.
For further information:
ANGLE plc +44 (0) 1483 343434
Andrew Newland, Chief Executive
Ian Griffiths, Finance Director
Andrew Holder, Head of Investor Relations
finnCap Ltd (NOMAD and Joint Broker)
Corporate Finance - Carl Holmes, Simon
Hicks, Teddy Whiley
ECM - Alice Lane, Sunila de Silva +44 (0)20 7220 0500
WG Partners (Joint Broker)
Claes Spång, Nigel Barnes, Nigel Birks +44 (0) 203 705 9330
Beech Hill Securities (US Broker)
George Billington +1 646 352 1368
FTI Consulting
Simon Conway, Ciara Martin, Stephanie Cuthbert +44 (0) 203 727 1000
Matthew Ventimiglia (US) +1 (212) 850 5624
This announcement contains inside information for the purposes
of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it
forms part of UK domestic law by virtue of the European Union
(Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with
the company's obligations under Article 17 of MAR. In addition,
market soundings (as defined in MAR) were taken in respect of the
Placing with the result that certain persons became aware of inside
information (as defined in MAR), as permitted by MAR. Due to the
publication of this Announcement, those persons that received
inside information in a market sounding are no longer in possession
of such inside information relating to the Company and its
securities.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ROIFIMBTMTITTMB
(END) Dow Jones Newswires
June 25, 2021 02:00 ET (06:00 GMT)
Angle (LSE:AGL)
Historical Stock Chart
From Feb 2024 to Mar 2024
Angle (LSE:AGL)
Historical Stock Chart
From Mar 2023 to Mar 2024